Restart of the Johnson & Johnson COVID-19 vaccine: A doctor explains why benefits far outweigh risks

Editor’s note: The Centers for Disease Control and Prevention and the Food and Drug Administration lifted the pause on the Johnson & Johnson COVID-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots. Also, close monitoring of …

Impact of COVID-19 on racial-ethnic minorities among persons with opioid use disorder

The COVID-19 pandemic has highlighted health disparities for people of color, who have been disproportionately affected by the pandemic. People with opioid use disorder (OUD) faced unique challenges when many mental health and addiction services were forced to scale back operations or temporarily close when social distancing guidelines were put in place.

Genomic study points to new treatment approaches for advanced small-cell lung cancer

A new study of advanced small-cell lung cancer (SCLC) led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) has identified molecular patterns linked to patients developing resistance to certain therapies.

Study finds increased risk of serious opioid events in mothers, regardless of dose

A new study from Vanderbilt University Medical Center researchers finds that new mothers who receive opioids after uncomplicated vaginal births face an increased risk of serious opioid-related events regardless of the opioid dosage, a finding that could significantly impact care delivery.

Researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant

A small study from Mayo Clinic researchers raises the concern that some transplant patients may have a limited immune response after being vaccinated for COVID-19 with an mRNA vaccine. Their findings are published as a letter to the editor in the American Journal of Transplantation.